908 Devices Inc. (NASDAQ:MASS) Insider Sells $22,535.76 in Stock

908 Devices Inc. (NASDAQ:MASS) insider Michael S. Turner sold 9,672 shares of the stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $2.33, for a total transaction of $22,535.76. Following the sale, the insider now directly owns 24,603 shares of the company’s stock, valued at $57,324.99. This represents a 28.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

908 Devices Price Performance

Shares of 908 Devices stock opened at $2.55 on Friday. 908 Devices Inc. has a 52 week low of $1.81 and a 52 week high of $7.91. The stock has a 50 day moving average price of $2.35 and a two-hundred day moving average price of $3.26.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the stock. Leerink Partners restated a “market perform” rating and issued a $4.00 target price (down previously from $12.00) on shares of 908 Devices in a report on Wednesday, November 13th. Stifel Nicolaus dropped their price objective on 908 Devices from $17.00 to $6.00 and set a “buy” rating on the stock in a research note on Wednesday, November 13th. Stephens reiterated an “overweight” rating and issued a $6.00 target price on shares of 908 Devices in a report on Wednesday, January 15th. Weiss Ratings restated a “sell (e+)” rating on shares of 908 Devices in a report on Saturday, February 1st. Finally, Leerink Partnrs lowered shares of 908 Devices from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 13th. Two investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, 908 Devices presently has a consensus rating of “Moderate Buy” and a consensus target price of $5.33.

Institutional Investors Weigh In On 908 Devices

A number of institutional investors and hedge funds have recently made changes to their positions in the business. 49 Wealth Management LLC increased its holdings in 908 Devices by 16.2% during the 3rd quarter. 49 Wealth Management LLC now owns 31,099 shares of the company’s stock worth $108,000 after purchasing an additional 4,343 shares in the last quarter. State Street Corp grew its holdings in 908 Devices by 1.2% during the third quarter. State Street Corp now owns 479,044 shares of the company’s stock worth $1,662,000 after buying an additional 5,704 shares in the last quarter. Geode Capital Management LLC raised its position in 908 Devices by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 567,788 shares of the company’s stock valued at $1,970,000 after buying an additional 6,634 shares during the last quarter. SG Americas Securities LLC purchased a new position in 908 Devices during the 3rd quarter worth $36,000. Finally, B. Riley Wealth Advisors Inc. bought a new stake in shares of 908 Devices in the 3rd quarter worth $45,000. Institutional investors and hedge funds own 88.06% of the company’s stock.

About 908 Devices

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.